Supreme Court to Decide on Abortion Pill Mifepristone's Future

The case could redefine FDA's authority and access to abortion medication, with arguments starting next week.

The Supreme Court is set to hear arguments on the FDA's approval of the abortion medication mifepristone, with implications for its availability and the FDA's authority.
Since 2000, mifepristone has been used for abortions in the early weeks of pregnancy, with updated guidelines in 2016 and 2021 expanding access.
The Alliance for Hippocratic Medicine filed a lawsuit to block mifepristone, arguing the FDA removed necessary safety safeguards.
The case has sparked a debate over the role of judges in evaluating the scientific decisions of agencies like the FDA.
A ruling on the case is expected in the next three months and could have significant legal, social, and political implications.